Impacts on health outcomes and on resource utilisation of home-based parenteral chemotherapy administration: a systematic review protocol

BMJ Open. 2018 May 9;8(5):e020594. doi: 10.1136/bmjopen-2017-020594.

Abstract

Introduction: Despite the demonstrated feasibility and policies to enable more to receive chemotherapy at home, in a few countries, parenteral chemotherapy administration at home remains currently marginal. Of note, findings of different studies on health outcomes and resources utilisation vary, leading to conflicting results. This protocol outlines a systematic review that seeks to synthesise and critically appraise the current state of evidence on the comparison between home setting and hospital setting for parenteral chemotherapy administration within the same high standards of clinical care.

Methods and analysis: This protocol has been prepared following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols approach. Electronic searches will be conducted on bibliographic databases selected from the earliest available data through 15 November 2017 published in French and English languages. Additional potential papers in the selected studies and grey literature will be also included in the review. The review will include all types of studies exploring patients receiving anticancer drugs for injection at home compared with patients receiving the drugs in a hospital setting, and will assess at least one of the following criteria: patients' health outcomes, patients' or caregivers' satisfaction, resource utilisation with cost savings, and incentives and/or barriers of each admission setting according to patients' and relatives' points of view. Two reviewers will independently screen studies and extract relevant data from the included studies. Methodological quality of studies will be assessed using the 'Quality Assessment Tool for Quantitative Studies' developed by the Effective Public Health Practice Project tool, in addition to the Consolidated Health Economic Evaluation Reporting Standards statement for economic studies.

Ethics and dissemination: As the review is focused on the analysis of secondary data, it does not require ethics approval. The results of the study will be disseminated through articles in peer-reviewed journals and trade publications, as well as presentations at relevant conferences.

Prospero registration number: CRD42017068164.

Keywords: chemotherapy; health economics; hospital at home; organisation of health services; public health; qualitative research.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Health Resources* / statistics & numerical data
  • Home Care Services* / statistics & numerical data
  • Humans
  • Infusions, Parenteral* / methods
  • Infusions, Parenteral* / statistics & numerical data
  • Neoplasms* / drug therapy
  • Neoplasms* / economics
  • Patient Acceptance of Health Care* / statistics & numerical data
  • Patient Outcome Assessment*
  • Research Design
  • Systematic Reviews as Topic